Morphosys plans 2024 application for cancer drug - share pri

The drug researcher Morphosys has achieved a breakthrough in clinical trials with its promising drug pelabresib against the rare blood cancer myelofibrosis. In a pivotal study, the Bavarians hit their...

Related Keywords

United States , Jean Paul Kress , Tim Demuth , Drug Administration , Constellation Pharmaceuticals , Paul Kress , Markets ,